Key result
Preprocedural left ventricular deceleration time < 160 ms was independently associated with increased all-cause mortality among TAVR patients with mild postprocedural aortic regurgitation (HR 1.74; 95% CI 1.14-2.60; P=0.01).
Why the study?
Does preprocedural left ventricular deceleration time < 160 ms predict adverse outcomes in patients who develop aortic regurgitation following TAVR?
Cohort (n=418)
Does preprocedural left ventricular deceleration time < 160 ms predict adverse outcomes in patients who develop aortic regurgitation following TAVR?
Hazard Ratio: 1.74 (95% CI 1.14–2.6)
p-value: p=0.01
Preprocedural impairment of left ventricular filling, indicated by a short deceleration time, is an independent predictor of adverse late clinical outcomes in patients who develop aortic regurgitation after TAVR.
Short preprocedural deceleration time may flag higher-risk TAVR patients with mild AR; hypothesis-generating for risk stratification and needs prospective validation.
OBJECTIVES: To investigate the impact of preprocedural left ventricular (LV) diastolic function on outcomes of patients with postprocedural aortic regurgitation (ARpost ) following transcatheter aortic valve replacement (TAVR). BACKGROUND: The predictors and mechanisms of the increased mortality in patients with ARpost are inadequately defined. METHODS: Baseline clinical and echocardiographic variables from a prospective TAVR registry were analyzed. Preprocedural correlates of late outcomes (all-cause mortality and the composite of mortality, stroke, heart failure, and new-onset atrial fibrillation) were examined according to the presence and severity of ARpost . RESULTS: Of the 418 patients undergoing TAVR, ARpost was present in 212 (51%): mild 36%, moderate-severe 15%. Mean follow-up was 909 ± 489 days. All-cause mortality and composite endpoint rates were significantly increased in patients with moderate-severe ARpost compared with patients with either none or only mild ARpost (38, 22, 21%, P = 0.02; and, 56, 35, 40%, P = 0.01; respectively). Moderate-severe (though not mild) ARpost was independently associated with mortality and the composite endpoint (HR = 1.93 [95%CI 1.15-3.14], P = 0.01; HR = 1.85 [95%CI 1.22-2.77], P = 0.004], respectively). By multivariate analysis, preprocedural LV deceleration time (DT) < 160 ms was independently associated with the risk of all-cause mortality and the composite endpoint among patients with mild AR (HR = 1.74 [95%CI 1.14-2.60], P = 0.01; and, HR = 1.73 [95%CI 1.23-2.41], P = 0.002, respectively) and moderate-severe ARpost (HR = 1.81 [95%CI 1.28-2.51], P < 0.001; HR = 1.86 [95%CI 0.22-2.80], P = 0.004, respectively). CONCLUSIONS: Preprocedural impairment of LV filling, reflected by short DT, portends an adverse prognosis in TAVR patients who develop ARpost independently of other clinical and echocardiocardigraphic measures including AS severity and systolic LV function.
No takes yet. Share an insight, caveat, or question.
Halkin et al. (2015) conducted a cohort in Postprocedural aortic regurgitation following transcatheter aortic valve replacement (n=418). Preprocedural left ventricular deceleration time < 160 ms vs. Longer deceleration time was evaluated on All-cause mortality among patients with mild postprocedural aortic regurgitation (HR 1.74, 95% CI 1.14-2.60, p=0.01). Preprocedural left ventricular deceleration time < 160 ms was independently associated with increased all-cause mortality among TAVR patients with mild postprocedural aortic regurgitation (HR 1.74; 95% CI 1.14-2.60; P=0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: